 |
Belonging
to a diabetes patients' association is predictive of better metabolic
control |
| |
Belonging to a patients' organization was associated
with better HbA(1c) in T1DM. In T2DM, which progresses relentlessly,
similar HbA(1c) levels and better lipid profiles were observed,
despite longer known disease durations and lower beta-cell function
(PubMed) |
| |
|
|
Sir
Ian launches diabetes centre |
| |
Former cricketer Sir Ian Botham has launched
the construction of a new diabetes centre in Surrey (BBC, UK) |
| |
|
|
Diabetics
missing out on life saving medication |
| |
This primary care project shows that despite
their high cardiovascular risk, one in four patients with diabetes
are not being treated with prophylactic aspirin and/or statins – medicines that could prevent their death from complications of their disease
(Royal Pharmaceutical Society of Great Britain) |
| |
|
|
Dual-wave
insulin pump improves postprandial glycemia in type 1 diabetic
children |
| |
Compared to normal bolus, PPG was significantly
reduced (by 47%) with a dual-wave bolus before low-glycemic index
meals, thus also reducing the risk of hypoglycemic events (American
Diabetes Association) |
| |
|
|
How
can we best prevent new foot ulcers in people with diabetes? |
| |
Little evidence from randomised controlled trials
is available to inform clinical guidelines on preventing diabetic
foot ulcers. However, the effects of interventions that explicitly
focus on foot health, specialist foot care, pressure deflection,
and patient education have not been rigorously evaluated (BMJ,
UK) |
| |
|
|
Hepatic
dysfunction and insulin insensitivity in type 2 diabetes mellitus:
a critical target for insulin-sensitizing agents |
| |
The current review addresses this topic from
the perspective of the role of the liver in maintaining glucose
homeostasis, its key involvement in the pathogenesis of type 2
diabetes and the tools currently available to reduce hepatic insulin
insensitivity (Diabetes, Obesity and Metabolism) |
| |
|
|
A
longitudinal study of affective and anxiety disorders, depressive
affect and diabetes distress in adults with Type 2 diabetes |
| |
The high prevalence of comorbid disorders and
the persistence of depressive affect and diabetes distress over
time highlight the need for both repeated mental health and diabetes
distress screening at each patient contact (Diabetic Medicine) |
| |
|
|
Depression
in Patients with Diabetes: Does It Impact Clinical Goals? |
| |
Depression seems to have a variable impact on
achieving these clinical goals, perhaps because the goals have
differing measurement logistics and biological profiles (Journal
of the American Board of Family Medicine ) |
| |
|
|
Intensive
Lipid Lowering With Atorvastatin in Patients With Coronary Artery
Disease, Diabetes, and Chronic Kidney Disease |
| |
Patients with diabetes, stable coronary artery
disease, and mild to moderate CKD experience marked reduction in
cardiovascular events with intensive lipid lowering, in contrast
to previous observations in patients with diabetes and end-stage
renal disease (Mayo Clinic Proceedings) |
| |
|
|
Physicians
Eager To Increase Their First- And Second-Line Prescriptions
For Januvia For The Treatment Of Type 2 Diabetes |
| |
Endocrinologists and primary care physicians
expect to shift their third- or later-line Januvia use to earlier
lines of therapy in the next two years (Decision Resources) |
| |
|
|
Weight
changes in type 2 diabetes and the impact of gender |
| |
This study provides evidence that weight gain
is not a necessary consequence of the treatment of type 2 diabetes.
Women were more successful than men in losing weight, and diet,
with or without the addition of metformin, was the treatment type
most usually associated with weight loss (Diabetes, Obesity and
Metabolism) |
| |
|
